Comment on "Drug survival analysis is not a good method for assessing the safety or effectiveness of systemic therapies in psoriasis"
SourceActas Dermo-Sifiliograficas, 108, 7, (2017), pp. 695-696
Article / Letter to editor
Display more detailsDisplay less details
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.